Patients aren't the only ones disappointed by delays in the Illinois medical marijuana program. A newly released report says investors are watching their hopes for financial returns fade, at least for this year.
A market research group tells investors to expect the 2015 Illinois market to be worth $5.7 million because of delays. The report from ArcView Market Research sees the market expanding to $36 million in 2016 as the program gets off the ground.
Company CEO Troy Dayton says Illinois Gov. Bruce Rauner's plan to conduct a legal review of the program and former Gov. Pat Quinn's failure to award business licenses before leaving office affect the numbers.
Peter Schweda of Downers Grove is a partner in an Illinois cultivation center business. He says investors are getting cold feet.
